JANSSEN PHARMS FDA Approval NDA 019697

NDA 019697

JANSSEN PHARMS

FDA Drug Application

Application #019697

Documents

Letter2007-05-09
Letter2012-06-20
Letter2013-10-04
Letter2013-10-04
Label2013-11-20
Label2012-07-13
Letter2008-06-03
Letter2013-10-04
Letter2013-10-04
Letter2015-05-04
Review2009-01-12
Review2009-01-12
Review2009-01-12
Review2009-01-12
Review2009-01-12
Review2009-01-12
Review2009-01-12
Review2009-01-12
Review2009-01-12
Review2009-01-12
Label2007-05-07
Label2013-10-04
Label2015-05-04
Review2009-01-12
Review2009-01-12
Review2009-01-12
Review2009-01-12
Review2009-01-12
Review2009-01-12
Review2009-01-12
Review2009-01-12
Review2009-01-12
Label2017-08-10
Letter2017-08-15
Pediatric Medical Review1900-01-01
Pediatric Clinical Pharmacology Review1900-01-01
Pediatric Statistical Review1900-01-01
Pediatric Written Request1900-01-01
Pediatric Amendment 11900-01-01
Pediatric Amendment 21900-01-01
Label2022-05-02
Letter2022-05-03

Application Sponsors

NDA 019697JANSSEN PHARMS

Marketing Status

Prescription001
Discontinued002

Application Products

001TABLET;ORAL-280.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG1ORTHO TRI-CYCLENETHINYL ESTRADIOL; NORGESTIMATE
002TABLET;ORAL-210.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG0ORTHO TRI-CYCLENETHINYL ESTRADIOL; NORGESTIMATE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1992-07-03STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1995-02-16STANDARD
LABELING; LabelingSUPPL3AP1994-06-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1994-12-28STANDARD
LABELING; LabelingSUPPL5AP1996-01-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1995-08-21STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1995-08-21STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1995-11-30STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1996-02-07STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1996-02-14STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1996-08-02STANDARD
LABELING; LabelingSUPPL12AP1998-04-20STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1996-08-21STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1999-10-20STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1999-11-02STANDARD
LABELING; LabelingSUPPL18AP1999-11-22STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1999-09-30STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL21AP2000-01-05STANDARD
LABELING; LabelingSUPPL22AP2000-06-05STANDARD
LABELING; LabelingSUPPL24AP2001-01-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL25AP2000-08-30STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL27AP2001-07-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL28AP2002-01-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL29AP2002-06-03STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL30AP2002-09-06STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL32AP2003-01-03STANDARD
LABELING; LabelingSUPPL34AP2007-05-03STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL41AP2008-05-30N/A
LABELING; LabelingSUPPL42AP2013-10-03STANDARD
LABELING; LabelingSUPPL44AP2012-06-18STANDARD
LABELING; LabelingSUPPL45AP2013-10-02STANDARD
LABELING; LabelingSUPPL47AP2013-10-02STANDARD
LABELING; LabelingSUPPL50AP2013-10-02STANDARD
LABELING; LabelingSUPPL52AP2015-05-01STANDARD
LABELING; LabelingSUPPL54AP2017-08-09STANDARD
LABELING; LabelingSUPPL58AP2022-04-29STANDARD

Submissions Property Types

SUPPL2Null0
SUPPL4Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0
SUPPL10Null0
SUPPL11Null0
SUPPL13Null0
SUPPL15Null0
SUPPL16Null0
SUPPL19Null0
SUPPL21Null0
SUPPL25Null0
SUPPL27Null0
SUPPL28Null0
SUPPL29Null0
SUPPL30Null0
SUPPL32Null0
SUPPL41Null4
SUPPL42Null6
SUPPL44Null15
SUPPL45Null6
SUPPL47Null6
SUPPL50Null7
SUPPL52Null7
SUPPL54Null7
SUPPL58Null7

TE Codes

001PrescriptionAB

CDER Filings

JANSSEN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 19697
            [companyName] => JANSSEN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"ORTHO TRI-CYCLEN","activeIngredients":"ETHINYL ESTRADIOL; NORGESTIMATE","strength":"0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG","dosageForm":"TABLET;ORAL-28","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"ORTHO TRI-CYCLEN","activeIngredients":"ETHINYL ESTRADIOL; NORGESTIMATE","strength":"0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG","dosageForm":"TABLET;ORAL-21","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"08\/09\/2017","submission":"SUPPL-54","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/019653s058,019697s054lbl.pdf\"}]","notes":""},{"actionDate":"05\/01\/2015","submission":"SUPPL-52","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/019653s056,019697s052,021690s001lbl.pdf\"}]","notes":""},{"actionDate":"10\/03\/2013","submission":"SUPPL-42","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"\"}]","notes":""},{"actionDate":"10\/02\/2013","submission":"SUPPL-47","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/019653Orig1s046,019697Orig1s042lbl.pdf\"}]","notes":""},{"actionDate":"06\/18\/2012","submission":"SUPPL-44","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/019653s048lbl.pdf\"}]","notes":""},{"actionDate":"05\/03\/2007","submission":"SUPPL-34","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/019653s037,019697s034lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"ORTHO TRI-CYCLEN","submission":"ETHINYL ESTRADIOL; NORGESTIMATE","actionType":"0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG","submissionClassification":"TABLET;ORAL-28","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"ORTHO TRI-CYCLEN","submission":"ETHINYL ESTRADIOL; NORGESTIMATE","actionType":"0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG","submissionClassification":"TABLET;ORAL-21","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2017-08-09
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.